Holen Sie sich die Stockscreener-App
0.6551
6.41%
-0.0449
Schlusskurs vom Vortag:
$0.70
Offen:
$0.711
24-Stunden-Volumen:
358.27K
Relative Volume:
0.36
Marktkapitalisierung:
$9.44M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-20.87M
KGV:
-0.4114
EPS:
-1.5924
Netto-Cashflow:
$-21.21M
1W Leistung:
+9.17%
1M Leistung:
-88.20%
6M Leistung:
-72.30%
1J Leistung:
-75.46%
1-Tages-Spanne:
$0.65
$0.711
1-Wochen-Bereich:
$0.6035
$0.79
52-Wochen-Spanne:
$0.5201
$7.20
Calcimedica Inc Stock (CALC) Company Profile
Firmenname
Calcimedica Inc
Sektor
Branche
Telefon
858-952-5500
Adresse
505 COAST BOULEVARD SOUTH, LA JOLLA
Compare CALC vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CALC
Calcimedica Inc
|
0.6551 | 10.09M | 0 | -20.87M | -21.21M | -1.5924 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Calcimedica Inc Stock (CALC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-29 | Herabstufung | H.C. Wainwright | Buy → Neutral |
Calcimedica Inc Aktie (CALC) Neueste Nachrichten
Should I set a stop loss on CalciMedica Inc.July 2025 Momentum & Weekly Watchlist for Consistent Profits - mfd.ru
Aug Highlights: What’s the fair value of DUK.PRA stockQuarterly Trade Review & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Earnings Risk: Does CalciMedica Inc meet Warren Buffetts criteria2025 Price Momentum & Technical Pattern Recognition Alerts - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
How Is The Market Feeling About CalciMedica Inc? - Benzinga
What is CalciMedica Inc.’s book value per shareWeekly Trend Summary & AI Enhanced Trading Signals - mfd.ru
CalciMedica downgraded to Neutral from Buy at H.C. Wainwright - TipRanks
This CalciMedica Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday - Benzinga
CalciMedica Shares Plunge After Discontinuing Phase II AKI Study - Citeline News & Insights
CalciMedica stock downgraded to Neutral by H.C. Wainwright after trial halt - Investing.com Canada
CalciMedica’s stock drops 75% on acute kidney injury trial termination - Clinical Trials Arena
CALC Stock Slumped 76% On Wednesday — Here’s Why - Asianet Newsable
CalciMedica discontinues AKI trial following safety concerns By Investing.com - Investing.com South Africa
CalciMedica discontinues Phase 2 KOURAGE trial following committee recommendation By Investing.com - Investing.com Nigeria
CalciMedica Discontinues Trial, Stock Faces Volatility - intellectia.ai
CalciMedica discontinues Phase 2 KOURAGE trial following committee recommendation - Investing.com
Calcimedica Discontinues Phase 2 Kourage Trial - TradingView
CalciMedica Ends KOURAGE Trial, Extends Cash Runway - TipRanks
Sector Update: Health Care - marketscreener.com
CalciMedica oversold on KOURAGE news, says Oppenheimer - TipRanks
CalciMedica ( CALC) Stock: Stops Phase 2 KOURAGE trial amid Enrollment Criteria Concerns - parameter.io
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Gold Jumps Over 4%; Seagate Shares Gain After Q2 Results - Benzinga
Calcimedica sags on halt of Auxora trial in acute kidney injury - bioworld.com
CalciMedica Pauses Kidney Study, Eyes New Trial In Pancreatitis - Benzinga
CalciMedica Shares Hit 52-Week Low After Ending Auxora Trial - marketscreener.com
Nasdaq Gains 150 Points; Starbucks Shares Rise After Strong Sales - Benzinga
CalciMedica stock craters as trial stopped over 'safety concern' - Fierce Biotech
CalciMedica tumbles as safety concerns halt trial of kidney injury drug - TradingView
CalciMedica stock plunges after discontinuing kidney injury trial By Investing.com - Investing.com Australia
CalciMedica stock plunges after discontinuing kidney injury trial - Investing.com
CalciMedica Halts Phase 2 KOURAGE Trial After Safety Review - TipRanks
CalciMedica discontinues AKI trial following safety concerns - Investing.com
CalciMedica announces discontinuation of Phase 2 KOURAGE clinical trial - TipRanks
CalciMedica Inc Discontinues Phase 2 KOURAGE Trial - TradingView
CalciMedica Announces Discontinuation of Phase 2 KOURAGE Trial in AKI Following Independent Data Monitoring Committee Recommendation - PR Newswire
Does CalciMedica Inc have consistent dividend growthSell Signal & Real-Time Market Sentiment Reports - baoquankhu1.vn
Aug Catalysts: Why is Neurocrine Biosciences Inc stock going upPortfolio Update Report & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Why CalciMedica Is A Stock To Watch - Nasdaq
Will CalciMedica Inc benefit from rising consumer demandEarnings Summary Report & Fast Moving Market Watchlists - baoquankhu1.vn
CalciMedica (NASDAQ:CALC) Upgraded to Sell at Wall Street Zen - Defense World
One new option listing on January 13th - TipRanks
Is MOTMQ stock a good choice for value investorsJuly 2025 PostEarnings & Free High Accuracy Swing Entry Alerts - ulpravda.ru
Will EDAG Engineering Group AG (ED4) stock recover faster than industryNew Guidance & Daily Oversold Stock Bounce Ideas - Улправда
Is CalciMedica Inc. stock a top momentum playJuly 2025 Momentum & Capital Protection Trade Alerts - Улправда
How CalciMedica Inc. stock reacts to job market data2025 Market WrapUp & Precise Swing Trade Alerts - Улправда
How CalciMedica Inc. stock reacts to global recession fearsJobs Report & Free Long-Term Investment Growth Plans - Улправда
2026 world cup usa national team qualification veteran players low block defense betting odds explained2025 AllTime Highs & AI Powered Market Entry Strategies - Улправда
Will Progress Software Corporation stock benefit from infrastructure spendingMarket Risk Summary & Growth Focused Entry Reports - ulpravda.ru
Investors Hope for Bounce in Meyer Apparel Limited After Selloff2025 Performance Recap & Stepwise Trade Signal Implementation - Улправда
Is Kennametal Inc. stock resilient to inflationQuarterly Portfolio Review & AI Driven Stock Price Forecasts - Улправда
Finanzdaten der Calcimedica Inc-Aktie (CALC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Calcimedica Inc-Aktie (CALC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Roberts Eric W | CHIEF BUSINESS OFFICER |
Sep 15 '25 |
Buy |
2.68 |
3,400 |
9,105 |
81,650 |
| Roberts Eric W | CHIEF BUSINESS OFFICER |
Sep 12 '25 |
Buy |
3.12 |
5,000 |
15,600 |
78,250 |
| Roberts Eric W | CHIEF BUSINESS OFFICER |
Sep 09 '25 |
Buy |
3.15 |
2,343 |
7,378 |
73,250 |
| Roberts Eric W | CHIEF BUSINESS OFFICER |
Aug 28 '25 |
Buy |
2.86 |
9,200 |
26,340 |
70,107 |
| Roberts Eric W | CHIEF BUSINESS OFFICER |
Aug 29 '25 |
Buy |
2.74 |
800 |
2,192 |
70,907 |
| Roberts Eric W | CHIEF BUSINESS OFFICER |
Aug 21 '25 |
Buy |
2.79 |
3,508 |
9,797 |
60,907 |
| Roberts Eric W | CHIEF BUSINESS OFFICER |
Aug 20 '25 |
Option Exercise |
1.53 |
15,000 |
22,950 |
179,706 |
| Roberts Eric W | CHIEF BUSINESS OFFICER |
Aug 20 '25 |
Buy |
2.72 |
2,000 |
5,440 |
57,399 |
| Roberts Eric W | CHIEF BUSINESS OFFICER |
Aug 19 '25 |
Buy |
2.79 |
1,000 |
2,790 |
55,399 |
| Hebbar Sudarshan | Chief Medical Officer |
Aug 19 '25 |
Buy |
2.82 |
9,563 |
26,962 |
61,539 |
1.12%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):